Molecular Medicine Research Center, College of Pharmacy, Yanbian University, Yanji, 133002, Jilin Province, China.
Molecular Medicine Research Center, College of Pharmacy, Yanbian University, Yanji, 133002, Jilin Province, China.
J Ethnopharmacol. 2021 Jun 12;273:113989. doi: 10.1016/j.jep.2021.113989. Epub 2021 Mar 4.
Glycyrrhiza glabra L., a traditional medicinal, has a history of thousands of years. It is widely used in clinic and has been listed in Chinese Pharmacopoeia. Licochalcone A is a phenolic chalcone compound and a characteristic chalcone of Glycyrrhiza glabra L. It has many pharmacological activities, such as anti-cancer, anti-inflammatory, anti-viral and anti-angiogenic activities.
In this study, we explored the anti-tumor activity and potential mechanism of licochalcone A in vitro and in vivo.
In vitro, the mechanism of licochalcone A at inhibiting PD-L1 expression was investigated by molecular docking, western blotting, RT-PCR, flow cytometry, immunofluorescence and immunoprecipitation assays. The co-culture model of T cells and tumor cells was used to detect the activity of cytotoxic T lymphocytes. Colony formation, EdU labelling and apoptosis assays were used to detect changes in cellular proliferation and apoptosis. In vivo, anti-tumor activity of licochalcone A was assessed in a xenograft model of HCT116 cells.
In the present study, we found that licochalcone A suppressed the expression of programmed cell death ligand-1 (PD-L1), which plays a key role in regulating the immune response. In addition, licochalcone A inhibited the expressions of p65 and Ras. Immunoprecipitation experiment showed that licochalcone A suppressed the expression of PD-L1 by blocking the interaction between p65 and Ras. In the co-culture model of T cells and tumor cells, licochalcone A pretreatment enhanced the activity of cytotoxic T lymphocytes and restored the ability to kill tumor cells. In addition, we showed that licochalcone A inhibited cell proliferation and promoted cell apoptosis by targeting PD-L1. In vivo xenograft assay confirmed that licochalcone A inhibited the growth of tumor xenografts.
In general, these results reveal the previously unknown properties of licochalcone A and provide new insights into the anticancer mechanism of this compound.
甘草(Glycyrrhiza glabra L.)是一种传统药用植物,已有数千年的应用历史。它在临床上被广泛应用,并已被列入中国药典。甘草查尔酮 A 是一种酚类查尔酮化合物,也是甘草(Glycyrrhiza glabra L.)的特征性查尔酮。它具有多种药理活性,如抗癌、抗炎、抗病毒和抗血管生成活性。
本研究旨在探讨甘草查尔酮 A 的体外和体内抗肿瘤活性及其潜在机制。
在体外,通过分子对接、western blot、RT-PCR、流式细胞术、免疫荧光和免疫沉淀实验研究甘草查尔酮 A 抑制 PD-L1 表达的机制。使用 T 细胞和肿瘤细胞共培养模型检测细胞毒性 T 淋巴细胞的活性。通过集落形成、EdU 标记和凋亡实验检测细胞增殖和凋亡的变化。在体内,采用 HCT116 细胞移植瘤模型评估甘草查尔酮 A 的抗肿瘤活性。
本研究发现,甘草查尔酮 A 抑制了程序性死亡配体 1(PD-L1)的表达,PD-L1 在调节免疫反应中起着关键作用。此外,甘草查尔酮 A 抑制了 p65 和 Ras 的表达。免疫沉淀实验表明,甘草查尔酮 A 通过阻断 p65 和 Ras 之间的相互作用抑制 PD-L1 的表达。在 T 细胞和肿瘤细胞共培养模型中,甘草查尔酮 A 预处理增强了细胞毒性 T 淋巴细胞的活性,并恢复了杀伤肿瘤细胞的能力。此外,我们表明,甘草查尔酮 A 通过靶向 PD-L1 抑制细胞增殖并促进细胞凋亡。体内异种移植实验证实,甘草查尔酮 A 抑制肿瘤异种移植物的生长。
总之,这些结果揭示了甘草查尔酮 A 的未知特性,并为该化合物的抗癌机制提供了新的见解。